Managing clinical research for allergic diseases and autoimmune disorders
Official title: RhoFED CDSMC
Funded at Rho Federal Systems Division, INC. · NIH-11325492 · Data updated 2026-11-12
This study is working on making clinical trials for allergies, asthma, and autoimmune diseases better and safer, so that patients like you can have access to improved treatments in the future.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rho Federal Systems Division, INC. NIH-funded |
| Lab location | 1 site (Durham, UNITED STATES) |
| Project start | May 8, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $297,494 |
| NIH project number | 3U01AI178773-03S1 |
| Project ID | NIH-11325492 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals suffering from allergic diseases, asthma, or autoimmune disorders.
✕Less likely to help
Patients with conditions unrelated to allergic diseases or autoimmune disorders may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the management of clinical trials related to allergic diseases, asthma, and autoimmune disorders. It aims to improve data management, safety monitoring, and specimen tracking through innovative technology and best practices. The project will utilize a structured approach with dedicated cores to ensure effective oversight and continuity in clinical research operations. Patients may benefit from improved clinical trial processes that could lead to better treatment options for their conditions.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and management strategies for patients with allergic diseases and autoimmune disorders.
How similar studies have gone: Previous research has shown success in improving clinical trial management through innovative data systems and safety monitoring.
Where this research is happening
-
Rho Federal Systems Division, INC.
Durham, United States Active
Researchers
- Principal investigator: Schmidt, Peter N. — Rho Federal Systems Division, INC.
- Study coordinator: Schmidt, Peter N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.